Staff editor

Case report: butyric acid, bifidobacterium and fructooligosaccharides in a young patient with Rhoemheld syndrome

Vegim Zhaku, from Tetovo University Faculty of Medicine, Macedonia, discussed the case of a male patient with palpitations, shortness of breath, epigastric discomfort and flatulence.

Probi® Sensia – New probiotic concept within cognitive health

Cognitive function, Mood, Sleep and Stress – keywords that are addressed in the new clinically supported probiotic solution, Probi® Sensia to be launched by Probi ® at SupplySide West in…

FMT donors: the importance of gut metabolite screening

Sara Deleu, researcher at KU Leuven, talks about the role of gut metabolite, as Butyric acid and other compounds, during the fecal microbiota transplantation.

Clinical Microbiomics A/S and CosmosID Inc. Merge to Create the Global Leader in Microbiome Research Services

The purpose of the new company is to help scientists worldwide understand how the microbiome influences health and well-being– from humans and animals to plants and the environment.

Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation

VE202 is an orally administered, rationally-defined bacterial consortium candidate for the treatment of ulcerative colitis

The ‘all biotic’ revolution: what is next and what do all these terms really mean?

George Paraskevakos, Executive Director at International Probiotics Association, discusses the future of the microbiome space.

Mood-Boosting Probiotics: the beneficial effects of Limosilactobacillus reuteri PBS072 and Bifidobacterium breve BB077

Specific probiotic strains can improve stress-related parameters in mothers after delivery.

Fecal Microbiota Transplantation: profiling of patients with pouchitis

Iris Dothan, from Rabin Medical Center, Israel, talks about the profiling of patient with pouchitis in order to determine the benefits from microbiome manipulation.

Live Biotherapeutics as cancer treatments: scientific and regulatory challenges

Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top